Pura Vida Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Pura Vida Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-21,643	Closed	-$3.38M	–	230
2022 Q2	$3.38M	Buy	+21,643	New	+$3.33M	0.2%	110
2017 Q2	–	Sell	-10,200	Closed	-$1.48M	–	81
2017 Q1	$1.48M	Buy	+10,200	New	+$1.33M	0.44%	58
2016 Q4	–	Sell	-33,936	Closed	-$4.12M	–	78
2016 Q3	$4.12M	Buy	33,936 +11,936	+54%	+$1.61M	1.25%	31
2016 Q2	$3.11M	Buy	22,000 +14,500	+193%	+$2.14M	1.32%	35
2016 Q1	$979K	Buy	+7,500	New	+$934K	0.45%	58
2015 Q4	–	Sell	-18,000	Closed	-$2.39M	–	82
2015 Q3	$2.39M	Hold	18,000	–	–	1.36%	33
2015 Q2	$3.46M	Sell	18,000 -14,500	-45%	-$2.6M	1.77%	22
2015 Q1	$5.62M	Buy	32,500 +27,500	+550%	+$4.72M	2.9%	8
2014 Q4	$819K	Buy	+5,000	New	+$830K	0.3%	62

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Pura Vida Investments's JAZZ Position: Q3 2022 in Review

Pura Vida Investments sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2022, closing a stake of 21,643 shares — an estimated $3.38M sold.

Pura Vida Investments first reported a position in JAZZ in Q4 2014 and held it in 9 quarters. The position peaked at $5.62M in Q1 2015. 468 funds tracked by Wall St. Rank hold JAZZ as of Q3 2022.

Pura Vida Investments reported no remaining Jazz Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Pura Vida Investments sold 21,643 Jazz Pharmaceuticals shares in Q3 2022, an estimated $3.38M.
Pura Vida Investments first reported a position in Jazz Pharmaceuticals in Q4 2014 and held it in 9 quarters.
Pura Vida Investments's Jazz Pharmaceuticals position peaked at $5.62M in Q1 2015.
468 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2022.

Based on Pura Vida Investments's 13F filing for Q3 2022, filed 14 Nov 2022.